Topiramate Patent Expiration

Topiramate is Used for preventing migraines in patients 12 years and older. It was first introduced by Janssen Pharmaceuticals Inc in its drug Topamax on Dec 24, 1996. Other drugs containing Topiramate are Trokendi Xr, Topamax Sprinkle, Qudexy Xr, Eprontia. 42 different companies have introduced drugs containing Topiramate.


Topiramate Patents

Given below is the list of patents protecting Topiramate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Eprontia US11433046 Compositions and methods for treating epilepsy, seizures and other conditions Aug 21, 2040 Azurity
Eprontia US11633374 Compositions and methods for treating epilepsy, seizures and other conditions Aug 21, 2040 Azurity
Eprontia US11826343 Compositions and methods for treating epilepsy, seizures and other conditions Aug 21, 2040 Azurity
Eprontia US11911362 Compositions and methods for treating epilepsy, seizures and other conditions Aug 21, 2040 Azurity
Qudexy Xr US10363224 Extended-release topiramate capsules Mar 19, 2033 Upsher Smith Labs
Qudexy Xr US8652527 Extended-release topiramate capsules Mar 19, 2033 Upsher Smith Labs
Qudexy Xr US8889190 Extended-release topiramate capsules Mar 19, 2033 Upsher Smith Labs
Qudexy Xr US9101545 Extended-release topiramate capsules Mar 19, 2033 Upsher Smith Labs
Qudexy Xr US9555005 Extended-release topiramate capsules Mar 19, 2033 Upsher Smith Labs
Trokendi Xr US8298576 Sustained-release formulations of topiramate Apr 04, 2028 Supernus Pharms
Trokendi Xr US10314790 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US8298580 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US8663683 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US8877248 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US8889191 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US8992989 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US9549940 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US9555004 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Trokendi Xr US9622983 Sustained-release formulations of topiramate Nov 16, 2027 Supernus Pharms
Topamax US7125560

(Pediatric)

Pharmaceutical composition of topiramate Sep 01, 2019

(Expired)

Janssen Pharms
Topamax Sprinkle US7125560

(Pediatric)

Pharmaceutical composition of topiramate Sep 01, 2019

(Expired)

Janssen Pharms
Topamax US7125560 Pharmaceutical composition of topiramate Mar 01, 2019

(Expired)

Janssen Pharms
Topamax Sprinkle US7125560 Pharmaceutical composition of topiramate Mar 01, 2019

(Expired)

Janssen Pharms
Topamax US5998380

(Pediatric)

Treatment of migraine Apr 13, 2016

(Expired)

Janssen Pharms
Topamax US6503884

(Pediatric)

Migraine treatment method using topiramate and related compounds Apr 13, 2016

(Expired)

Janssen Pharms
Topamax US7018983

(Pediatric)

Treatment of migraine Apr 13, 2016

(Expired)

Janssen Pharms
Topamax US7498311

(Pediatric)

Treatment of migraine Apr 13, 2016

(Expired)

Janssen Pharms
Topamax Sprinkle US5998380

(Pediatric)

Treatment of migraine Apr 13, 2016

(Expired)

Janssen Pharms
Topamax Sprinkle US6503884

(Pediatric)

Migraine treatment method using topiramate and related compounds Apr 13, 2016

(Expired)

Janssen Pharms
Topamax Sprinkle US7018983

(Pediatric)

Treatment of migraine Apr 13, 2016

(Expired)

Janssen Pharms
Topamax Sprinkle US7498311

(Pediatric)

Treatment of migraine Apr 13, 2016

(Expired)

Janssen Pharms
Topamax US5998380 Treatment of migraine Oct 13, 2015

(Expired)

Janssen Pharms
Topamax US6503884 Migraine treatment method using topiramate and related compounds Oct 13, 2015

(Expired)

Janssen Pharms
Topamax US7018983 Treatment of migraine Oct 13, 2015

(Expired)

Janssen Pharms
Topamax US7498311 Treatment of migraine Oct 13, 2015

(Expired)

Janssen Pharms
Topamax Sprinkle US5998380 Treatment of migraine Oct 13, 2015

(Expired)

Janssen Pharms
Topamax Sprinkle US6503884 Migraine treatment method using topiramate and related compounds Oct 13, 2015

(Expired)

Janssen Pharms
Topamax Sprinkle US7018983 Treatment of migraine Oct 13, 2015

(Expired)

Janssen Pharms
Topamax Sprinkle US7498311 Treatment of migraine Oct 13, 2015

(Expired)

Janssen Pharms



A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Topiramate's patents.

Given below is the list recent legal activities going on the following patents of Topiramate.

Activity Date Patent Number
Patent litigations
Payment of Maintenance Fee, 12th Year, Large Entity 30 Apr, 2024 US8298580(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 13 Feb, 2023 US9101545
Payment of Maintenance Fee, 4th Year, Large Entity 30 Jan, 2023 US10363224
Payment of Maintenance Fee, 4th Year, Large Entity 12 Dec, 2022 US10314790(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 18 May, 2022 US8889191(Litigated)
Payment of Maintenance Fee, 8th Year, Large Entity 18 May, 2022 US8889190
Payment of Maintenance Fee, 8th Year, Large Entity 04 May, 2022 US8877248
Payment of Maintenance Fee, 8th Year, Large Entity 18 Aug, 2021 US8652527(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 19 Oct, 2020 US9622983(Litigated)
Payment of Maintenance Fee, 4th Year, Large Entity 31 Jul, 2020 US9555004(Litigated)


Topiramate's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Topiramate Generic API Manufacturers

Several generic applications have been filed for Topiramate. The first generic version for Topiramate was by Accord Healthcare Inc and was approved on Mar 27, 2009. And the latest generic version is by Amta Labs Ltd and was approved on Dec 3, 2024.

Given below is the list of companies who have filed for Topiramate generic, along with the locations of their manufacturing plants worldwide.


1. ACCORD HLTHCARE

Accord Healthcare Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Accord Hlthcare.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Mar 27, 2009
50MG

tablet Prescription ORAL AB Mar 27, 2009
100MG

tablet Prescription ORAL AB Mar 27, 2009
200MG

tablet Prescription ORAL AB Mar 27, 2009





2. ACTAVIS LABS FL

Actavis Laboratories Fl Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

capsule, extended release Prescription ORAL AB1 Mar 10, 2023
25MG

capsule, extended release Prescription ORAL AB1 Mar 10, 2023
100MG

capsule, extended release Prescription ORAL AB1 Mar 10, 2023
200MG

capsule, extended release Prescription ORAL AB1 Mar 10, 2023





3. ACTAVIS TOTOWA

Actavis Totowa Llc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Actavis Totowa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Discontinued ORAL N/A Feb 27, 2013
100MG

tablet Discontinued ORAL N/A Feb 27, 2013
25MG

tablet Discontinued ORAL N/A Feb 27, 2013
50MG

tablet Discontinued ORAL N/A Feb 27, 2013


Manufacturing Plant Locations
New

Actavis Totowa's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Actavis Totowa as present at those locations.

Country City Firm Name
United States
Totowa Actavis Totowa LLC
Little Falls Actavis Totowa LLC





4. AIPING PHARM INC

Aiping Pharmaceutical Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Aiping Pharm Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Jan 7, 2010
200MG

tablet Discontinued ORAL N/A Jan 7, 2010
100MG

tablet Discontinued ORAL N/A Jan 7, 2010
50MG

tablet Discontinued ORAL N/A Jan 7, 2010





5. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

capsule, extended release Discontinued ORAL N/A Aug 15, 2023
100MG

capsule, extended release Discontinued ORAL N/A Aug 15, 2023
25MG

capsule, extended release Discontinued ORAL N/A Aug 15, 2023
200MG

capsule, extended release Discontinued ORAL N/A Aug 15, 2023


Manufacturing Plant Locations
New

Ajanta Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Ajanta Pharma Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Ajanta Pharma Ltd.





6. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 6 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

capsule, extended release Prescription ORAL AB1 Jun 20, 2023
25MG

capsule Prescription ORAL AB Jun 13, 2024
50MG

capsule, extended release Prescription ORAL AB1 Jun 20, 2023
200MG

capsule, extended release Prescription ORAL AB1 Jun 20, 2023
15MG

capsule Prescription ORAL AB Jun 13, 2024
25MG/ML

solution Prescription ORAL AB Oct 31, 2024





7. AMTA

Amta Labs Ltd has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Amta.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule, extended release Prescription ORAL AB2 Dec 3, 2024
50MG

capsule, extended release Prescription ORAL AB2 Dec 3, 2024
100MG

capsule, extended release Prescription ORAL AB2 Dec 3, 2024
150MG

capsule, extended release Prescription ORAL AB2 Dec 3, 2024
200MG

capsule, extended release Prescription ORAL AB2 Dec 3, 2024


Manufacturing Plant Locations
New

Amta's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Amta as present at those locations.

Country City Firm Name
United States
Raleigh Amtai Medical Equipment, INC





8. ASCENT PHARMS INC

Ascent Pharmaceuticals Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Ascent Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Aug 26, 2021
200MG

tablet Prescription ORAL AB Aug 26, 2021
50MG

tablet Prescription ORAL AB Aug 26, 2021
25MG

tablet Prescription ORAL AB Aug 26, 2021





9. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Mar 27, 2009
25MG

tablet Prescription ORAL AB Mar 27, 2009
50MG

tablet Prescription ORAL AB Mar 27, 2009
200MG

tablet Prescription ORAL AB Mar 27, 2009


Manufacturing Plant Locations
New

Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.

Country City Firm Name
India
Polepally, Mahaboob Nagar Aurobindo Pharma Limited
Medchal Aurobindo Pharma Ltd
Sangareddy Aurobindo Pharma Limited
Bachupally Aurobindo Pharma Limited
United States
East Windsor Aurobindo Pharma USA Inc





10. AUROBINDO PHARMA LTD

Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Prescription ORAL AB Sep 27, 2023
15MG

capsule Prescription ORAL AB Sep 27, 2023


Manufacturing Plant Locations
New

Aurobindo Pharma Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma Ltd as present at those locations.

Country City Firm Name
India
Medchal Aurobindo Pharma Ltd





11. BARR

Barr Laboratories Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Discontinued ORAL N/A Apr 15, 2009
100MG

tablet Discontinued ORAL N/A Mar 27, 2009
200MG

tablet Discontinued ORAL N/A Mar 27, 2009
15MG

capsule Discontinued ORAL N/A Apr 15, 2009


Manufacturing Plant Locations
New

Barr's manufacturing plants are situated in 4 countries - Mexico, Singapore, United States, Philippines. Given below are the details of these plant locations as well as the firm names of Barr as present at those locations.

Country City Firm Name
Mexico
Aldama Barra La Coma, S. De R.L
Singapore
Singapore Barramundi Asia Pte Ltd
United States
Madison Barriques Holding Company, LLC
Buffalo Barrel and Brine Inc
Englewood Barrett E. Cowan, MD
Hereford Barrett and Crofoot Feedyard, West
Greenwood Barr Enterprises, Inc.
Lake Barrington Barrington Ventures, Ltd
Arecibo Barreto Dairy, Inc.
Live Oak Barrington Dairy Farm
Brainerd Barrett Ag Service, Inc.
Commerce Barreras Meat Co
Barrett Barrett Farm Supply, Inc.
Lee Barrington Coffee Roasting Company, Inc.
Belvidere Barred Woods, LLC
Paso Robles Barreto Cellars
Somerset Barrett Distribution Centers Inc
Franklin Barrett Distribution Centers, Inc.
Forest Barr Laboratories Inc.
Memphis Barrett Distribution Centers
Machipongo Barrier Island Seafood
Swartz Creek Barrett Donut Mixes, Inc..
Curtis Bay Barrett Distribution Center
Newton Barrett Technology, LLC
Dillon Barretts Minerals Inc
Davie Barrier Technologies LLC
Montezuma Barrington Dairies
Hereford Barrett and Crofoot, LLP
Harrison Barrington Chemical Corporation
Randolph Barrett Farm
Philippines
Bulacan Barrio Fiesta Manufacturing Corporation





12. CHARTWELL

Chartwell Life Molecules Llc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Chartwell.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Discontinued ORAL N/A Sep 11, 2013
200MG

tablet Discontinued ORAL N/A Sep 11, 2013
100MG

tablet Discontinued ORAL N/A Sep 11, 2013
25MG

tablet Discontinued ORAL N/A Sep 11, 2013


Manufacturing Plant Locations
New

Chartwell's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Chartwell as present at those locations.

Country City Firm Name
United States
Congers Chartwell Life Sciences LLC
Carmel Chartwell Pharmaceuticals Carmel LLC
Richboro Chartwells Division of Compass Group / Commodities Locker
West Caldwell Chartwell Pharmaceuticals West Caldwell LLC
Congers Chartwell Pharmaceuticals LLC





13. CHARTWELL RX

Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Chartwell Rx.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Discontinued ORAL N/A Oct 14, 2009
15MG

capsule Discontinued ORAL N/A Oct 14, 2009





14. CIPLA LTD

Cipla Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Cipla Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Mar 27, 2009
50MG

tablet Prescription ORAL AB Mar 27, 2009
100MG

tablet Prescription ORAL AB Mar 27, 2009
200MG

tablet Prescription ORAL AB Mar 27, 2009


Manufacturing Plant Locations
New

Cipla Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Cipla Ltd as present at those locations.

Country City Firm Name
India
Bangalore Cipla Ltd.





15. DR REDDYS

Dr Reddys Laboratories Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Dr Reddys.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule, extended release Prescription ORAL AB1 Nov 17, 2023
200MG

capsule, extended release Prescription ORAL AB1 Nov 17, 2023
100MG

capsule, extended release Prescription ORAL AB1 Nov 17, 2023
50MG

capsule, extended release Prescription ORAL AB1 Nov 17, 2023





16. ENDO OPERATIONS

Endo Operations Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

capsule, extended release Prescription ORAL AB1 Mar 1, 2023
25MG

capsule, extended release Prescription ORAL AB1 May 4, 2023
100MG

capsule, extended release Prescription ORAL AB1 May 4, 2023
50MG

capsule, extended release Prescription ORAL AB1 May 4, 2023





17. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 6 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Prescription ORAL AB Jul 16, 2024
50MG

capsule, extended release Prescription ORAL AB2 Feb 1, 2021
100MG

capsule, extended release Prescription ORAL AB2 Feb 1, 2021
200MG

capsule, extended release Prescription ORAL AB2 Feb 1, 2021
150MG

capsule, extended release Prescription ORAL AB2 Feb 1, 2021
15MG

capsule Prescription ORAL AB Jul 16, 2024





18. HIKMA PHARMS

Hikma Pharmaceuticals has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Hikma Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

tablet Discontinued ORAL N/A Nov 25, 2013
25MG

tablet Discontinued ORAL N/A Nov 25, 2013
100MG

tablet Discontinued ORAL N/A Nov 25, 2013
200MG

tablet Discontinued ORAL N/A Nov 25, 2013





19. INVAGEN PHARMS

Invagen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Invagen Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Mar 27, 2009
100MG

tablet Prescription ORAL AB Mar 27, 2009
50MG

tablet Prescription ORAL AB Mar 27, 2009
25MG

tablet Prescription ORAL AB Mar 27, 2009





20. LUPIN LTD

Lupin Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

capsule, extended release Prescription ORAL AB1 Jul 11, 2024
200MG

capsule, extended release Prescription ORAL AB1 Jul 11, 2024
50MG

capsule, extended release Prescription ORAL AB1 Jul 11, 2024
25MG

capsule, extended release Prescription ORAL AB1 Jul 11, 2024


Manufacturing Plant Locations
New

Lupin Ltd's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Lupin Ltd as present at those locations.

Country City Firm Name
India
Aurangabad Lupin Ltd.





21. NATCO

Natco Pharma Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Natco.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Mar 27, 2009
50MG

tablet Discontinued ORAL N/A Mar 27, 2009
100MG

tablet Discontinued ORAL N/A Mar 27, 2009
200MG

tablet Discontinued ORAL N/A Mar 27, 2009


Manufacturing Plant Locations
New

Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.

Country City Firm Name
United Kingdom
Buckingham Natco Foods Ltd
Hayes Natco Cash and Carry
India
Hyderabad Natco Pharma Limited
Paravada Natco Pharma Limited
Rangareddy District Natco Pharma Ltd. - Chemical Division
Hyderabad NATCO PHARMA LTD
Chennai NATCO Pharma Limited Chemical Division Chennai
Rangareddy NATCO Pharma Limited





22. PLIVA HRVATSKA DOO

Pliva Hrvatska Doo has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Pliva Hrvatska Doo.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Discontinued ORAL N/A Mar 30, 2009
25MG

tablet Discontinued ORAL N/A Mar 30, 2009
50MG

tablet Discontinued ORAL N/A Mar 30, 2009
100MG

tablet Discontinued ORAL N/A Mar 30, 2009





23. ROXANE

Roxane Laboratories Inc has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Mar 27, 2009
50MG

tablet Discontinued ORAL N/A Mar 27, 2009
100MG

tablet Discontinued ORAL N/A Mar 27, 2009
200MG

tablet Discontinued ORAL N/A Mar 27, 2009





24. SENORES PHARMS

Senores Pharmaceuticals Inc has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Senores Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Prescription ORAL AB Oct 10, 2024
15MG

capsule Prescription ORAL AB Oct 10, 2024





25. STRIDES PHARMA

Strides Pharma Global Pte Ltd has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Strides Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
15MG

capsule Prescription ORAL AB Oct 14, 2009
25MG

capsule Prescription ORAL AB Oct 14, 2009


Manufacturing Plant Locations
New

Strides Pharma's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Strides Pharma as present at those locations.

Country City Firm Name
United States
East Brunswick Strides Pharma Inc.
Chestnut Ridge Strides Pharma, Inc.
India
Puducherry Strides Pharma Science Limited
Bangalore Strides Pharma Science Limited





26. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Prescription ORAL AB Mar 27, 2009
100MG

tablet Prescription ORAL AB Mar 27, 2009
50MG

tablet Prescription ORAL AB Mar 27, 2009
25MG

tablet Prescription ORAL AB Mar 27, 2009


Manufacturing Plant Locations
New

Sun Pharm's manufacturing plants are situated in 2 countries - United States, India. Given below are the details of these plant locations as well as the firm names of Sun Pharm as present at those locations.

Country City Firm Name
United States
Lexington Sun Pharmaceutical Industries Inc
Princeton SUN PHARMACEUTICAL INDUSTRIES INC
Billerica Sun Pharmaceutical Industries, Inc.
India
Vadodara Sun Pharmaceutical Industries Ltd.
Vadodara Sun Pharmaceutical Industries Ltd
Vadodara Sun Pharmaceutical Industries Limited - Karkhadi
Halol Sun Pharmaceutical Industries Ltd.
New Delhi Sun Pharmaceutical Industries Limited
Punjab Sun Pharmaceutical Industries, Inc.
Mohali Sun Pharmaceutical Industries Limited
Gurugram Sun Pharmaceutical Industries Limited (prev. Ranbaxy)
Bharuch Sun Pharmaceutical Industries Ltd
Malanpur, Bhind (District) Sun Pharmaceutical Industries Limited
Ahmednagar Sun Pharmaceutical Industries Limited
Kanchipuram Sun Pharmaceutical Industries Limited- Madhuranthagam
Dadra Sun Pharmaceutical Industries Limited
Baruch Sun Pharmaceutical Industries Ltd.





27. SUN PHARM INDS LTD

Sun Pharmaceutical Industries Ltd has filed for 3 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Sun Pharm Inds Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Discontinued ORAL N/A Mar 27, 2009
100MG

tablet Discontinued ORAL N/A Mar 27, 2009
200MG

tablet Discontinued ORAL N/A Mar 27, 2009





28. TEVA

Teva Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Prescription ORAL AB Apr 17, 2009
50MG

tablet Discontinued ORAL N/A Mar 27, 2009
100MG

tablet Discontinued ORAL N/A Mar 27, 2009
200MG

tablet Discontinued ORAL N/A Mar 27, 2009
15MG

capsule Prescription ORAL AB Apr 17, 2009


Manufacturing Plant Locations
New

Teva's manufacturing plants are situated in 6 countries - United States, India, Canada, Czech Republic, Ireland, Israel. Given below are the details of these plant locations as well as the firm names of Teva as present at those locations.

Country City Firm Name
United States
Horsham Teva Branded Pharmaceutical Products R&D
Malvern Teva Branded Pharmaceutical Products R&D, Inc.
Fort Dodge TEVA Animal Health Inc
Miami Teva Branded Pharmaceutical Products R & D, Inc.
India
Gajraula, Amroha Teva API India Private Ltd.
Bhind Teva API India Ltd- Malanpur
Canada
Markham Teva Canada Limited
Scarborough Teva Canada Limited
Stouffville Teva Canada Limited
Czech Republic
Opava Teva Czech Industries s.r.o.
Ireland
Dundalk Teva Laboratories Ireland Ltd
Israel
Kiryat-Shmona TEVA Medical Ltd.





29. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Discontinued ORAL N/A Mar 27, 2009
25MG

tablet Discontinued ORAL N/A Mar 27, 2009
50MG

tablet Discontinued ORAL N/A Mar 27, 2009
100MG

tablet Discontinued ORAL N/A Mar 27, 2009





30. TWI PHARMS

Twi Pharmaceuticals Inc has filed for 2 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Twi Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Prescription ORAL AB Dec 5, 2023
15MG

capsule Prescription ORAL AB Dec 5, 2023





31. UNICHEM LABS LTD

Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Unichem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG

tablet Prescription ORAL AB Mar 27, 2009
50MG

tablet Prescription ORAL AB Mar 27, 2009
25MG

tablet Prescription ORAL AB Mar 27, 2009
200MG

tablet Prescription ORAL AB Feb 19, 2013





32. VIWIT PHARM

Viwit Pharmaceutical Co Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Viwit Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

tablet Prescription ORAL AB Mar 27, 2009
50MG

tablet Prescription ORAL AB Mar 27, 2009
100MG

tablet Prescription ORAL AB Mar 27, 2009
200MG

tablet Prescription ORAL AB Mar 27, 2009


Manufacturing Plant Locations
New

Viwit Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Viwit Pharm as present at those locations.

Country City Firm Name
China
Tengzhou Viwit Pharmaceutical Co., Ltd.





33. WATSON LABS

Watson Laboratories Inc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Discontinued ORAL N/A Apr 15, 2009
50MG

tablet Discontinued ORAL N/A Mar 27, 2009
100MG

tablet Discontinued ORAL N/A Mar 27, 2009
200MG

tablet Discontinued ORAL N/A Mar 27, 2009
15MG

capsule Discontinued ORAL N/A Apr 15, 2009





34. WOCKHARDT

Wockhardt Ltd has filed for 4 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Wockhardt.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

tablet Discontinued ORAL N/A Sep 1, 2010
25MG

tablet Discontinued ORAL N/A Sep 1, 2010
100MG

tablet Discontinued ORAL N/A Sep 1, 2010
50MG

tablet Discontinued ORAL N/A Sep 1, 2010


Manufacturing Plant Locations
New

Wockhardt's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Wockhardt as present at those locations.

Country City Firm Name
India
Aurangabad Wockhardt Limited
Solan, Nalagarh Wockhardt Limited - Baddi
Ankleshwar Wockhardt, Ltd.





35. XIAMEN LP PHARM CO

Xiamen Lp Pharmacuetical Co Ltd has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Xiamen Lp Pharm Co.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule, extended release Prescription ORAL AB2 Nov 5, 2024
50MG

capsule, extended release Prescription ORAL AB2 Nov 5, 2024
100MG

capsule, extended release Prescription ORAL AB2 Nov 5, 2024
150MG

capsule, extended release Prescription ORAL AB2 Nov 5, 2024
200MG

capsule, extended release Prescription ORAL AB2 Nov 5, 2024





36. ZYDUS

Zydus Worldwide Dmcc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Zydus.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG

capsule, extended release Prescription ORAL AB2 Nov 29, 2022
100MG

capsule, extended release Prescription ORAL AB2 Nov 29, 2022
25MG

capsule, extended release Prescription ORAL AB2 Nov 29, 2022
150MG

capsule, extended release Prescription ORAL AB2 Nov 29, 2022
200MG

capsule, extended release Prescription ORAL AB1 Oct 30, 2023


Manufacturing Plant Locations
New

Zydus's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Zydus as present at those locations.

Country City Firm Name
India
Jarod Zydus Lifesciences Limited
District Solan Zydus Lifesciences Limited
Ahmedabad Zydus Lifesciences Limited
Dabhasa Zydus Lifesciences Limited
Moraiya, Ahmedabad Zydus Lifesciences Limited
Matoda, Ahmedabad Zydus Animal Health and Investments Limited
Matoda Zydus Hospira Oncology Private Ltd.
Thane Zydus Lifesciences Limited
Matoda Zydus Lifesciences Limited
Ahmedabad ZYDUS LIFESCIENCES LIMITED
Ankleshwar Zydus Lifesciences Limited
United States
Pennington Zydus Pharmaceuticals (USA) Inc





37. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 1 generic for Topiramate. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG

capsule, extended release Discontinued ORAL N/A Feb 9, 2023





38. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Topiramate. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG

capsule Prescription ORAL AB Oct 14, 2009
50MG

capsule Prescription ORAL N/A Oct 23, 2024
100MG

tablet Prescription ORAL AB Mar 27, 2009
200MG

tablet Prescription ORAL AB Mar 27, 2009
15MG

capsule Prescription ORAL AB Oct 14, 2009